These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 15596795)

  • 1. Sodium channel blockers and axonal protection in neuroinflammatory disease.
    Waxman SG
    Brain; 2005 Jan; 128(Pt 1):5-6. PubMed ID: 15596795
    [No Abstract]   [Full Text] [Related]  

  • 2. Axonal protection in multiple sclerosis--a particular need during remyelination?
    Smith KJ
    Brain; 2006 Dec; 129(Pt 12):3147-9. PubMed ID: 17132643
    [No Abstract]   [Full Text] [Related]  

  • 3. Conduction block and axonal degeneration co-occurring in a patient with axonal Guillain-Barré syndrome.
    Kokubun N; Shahrizaila N; Hirata K; Yuki N
    J Neurol Sci; 2012 Aug; 319(1-2):164-7. PubMed ID: 22656182
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuroprotection of axons with phenytoin in experimental allergic encephalomyelitis.
    Lo AC; Black JA; Waxman SG
    Neuroreport; 2002 Oct; 13(15):1909-12. PubMed ID: 12395089
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sodium channels contribute to microglia/macrophage activation and function in EAE and MS.
    Craner MJ; Damarjian TG; Liu S; Hains BC; Lo AC; Black JA; Newcombe J; Cuzner ML; Waxman SG
    Glia; 2005 Jan; 49(2):220-9. PubMed ID: 15390090
    [TBL] [Abstract][Full Text] [Related]  

  • 6. What is the role of axonal ion channels in multiple sclerosis?
    Correale J; Marrodan M; Benarroch EE
    Neurology; 2020 Jul; 95(3):120-123. PubMed ID: 32482838
    [No Abstract]   [Full Text] [Related]  

  • 7. Factors directly affecting impulse transmission in inflammatory demyelinating disease: recent advances in our understanding.
    Smith KJ; Hall SM
    Curr Opin Neurol; 2001 Jun; 14(3):289-98. PubMed ID: 11371750
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Renegade nuclear enzymes disrupt axonal integrity.
    Miller RH
    Nat Neurosci; 2010 Feb; 13(2):143-4. PubMed ID: 20104203
    [No Abstract]   [Full Text] [Related]  

  • 9. Blockers of sodium and calcium entry protect axons from nitric oxide-mediated degeneration.
    Kapoor R; Davies M; Blaker PA; Hall SM; Smith KJ
    Ann Neurol; 2003 Feb; 53(2):174-80. PubMed ID: 12557283
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sodium-mediated axonal degeneration in inflammatory demyelinating disease.
    Bechtold DA; Smith KJ
    J Neurol Sci; 2005 Jun; 233(1-2):27-35. PubMed ID: 15894334
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sural-sparing is seen in axonal as well as demyelinating forms of Guillain-Barré syndrome.
    Umapathi T; Li Z; Verma K; Yuki N
    Clin Neurophysiol; 2015 Dec; 126(12):2376-80. PubMed ID: 25743269
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Axonal protection in experimental autoimmune neuritis by the sodium channel blocking agent flecainide.
    Bechtold DA; Yue X; Evans RM; Davies M; Gregson NA; Smith KJ
    Brain; 2005 Jan; 128(Pt 1):18-28. PubMed ID: 15509620
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Axonopathy in the pathogenesis of multiple sclerosis, peripheral diffuse and local motor neuropathies and motor neuron disease].
    Merkulov IuA; Merkulova DM; Iosifova OA; Zavalishin IA
    Zh Nevrol Psikhiatr Im S S Korsakova; 2010; 110(8):4-7. PubMed ID: 20823822
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sensory nerve conduction in demyelinating and axonal Guillain-Barré syndromes.
    Kuwabara S; Ogawara K; Misawa S; Mizobuchi K; Sung JY; Kitano Y; Mori M; Hattori T
    Eur Neurol; 2004; 51(4):196-8. PubMed ID: 15159599
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Guillain-Barré syndrome in Pakistan: similarity of demyelinating and axonal variants.
    Shafqat S; Khealani BA; Awan F; Abedin SE
    Eur J Neurol; 2006 Jun; 13(6):662-5. PubMed ID: 16796593
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanisms of axon-glial injury of the optic nerve.
    Compston A
    Eye (Lond); 2004 Nov; 18(11):1182-7. PubMed ID: 15534604
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acute axonal damage in three different murine models of multiple sclerosis: A comparative approach.
    Höflich KM; Beyer C; Clarner T; Schmitz C; Nyamoya S; Kipp M; Hochstrasser T
    Brain Res; 2016 Nov; 1650():125-133. PubMed ID: 27592741
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Keeping it simple: is there a need for the various subtyping of axonal forms of Guillain-Barre syndrome?
    Yuki N; Shahrizaila N
    J Neurol Neurosurg Psychiatry; 2011 Jun; 82(6):592. PubMed ID: 21551171
    [No Abstract]   [Full Text] [Related]  

  • 19. Conduction block in acute motor axonal neuropathy.
    Kokubun N; Nishibayashi M; Uncini A; Odaka M; Hirata K; Yuki N
    Brain; 2010 Oct; 133(10):2897-908. PubMed ID: 20855419
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intravenous immunoglobulins versus plasmapheresis in older patients with Guillain-Barre syndrome.
    Rana SS; Rana S
    J Am Geriatr Soc; 1999 Nov; 47(11):1387-8. PubMed ID: 10573458
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.